Wobble Genomics appoints two high-profile non-executive directors

Scottish start-ups that are focussed on impact around climate change, energy solution and also food & water security.

Portfolio company ILC Therapeutics Ltd completes £3.5m funding round - to be used to accelerate development of hybrid interferon designed to combat viral infections in a round including Los Angeles-based lawyer and investor Robert Kopple; Eos Advisory; Scottish Enterprise; and members of ILCT's management

Wobble Genomics hails £1.2m investment round led by Eos Advisory

The recently rebranded Dxcover have been back in the press - taking about a study which has been hugely successful in identifying tumours as small as 0.2cm from a simple blood test - which has been hailed as “transformative” for patients and doctors.

Growth funding round by Chromacity Ltd to expedite international growth, especially in Asia. This £1.2m round included investment from Eos Advisory, Kelvin Capital, ESM INVESTMENTS LIMITED and Scottish Enterprise.

ENOUGH raises €42m ($51M) Series B to supercharge sustainable protein

Cumulus Oncology launches partnership with Lead Discovery Center GmbH – an exciting next chapter for this pioneering Eos portfolio company

ClinSpec Diagnostics Limited (ClinSpec Dx) reaches its round two funding target of £3.5 million from Norcliffe Capital Limited, the University of Strathclyde, Eos Advisory and the founders.

Eos portfolio Cumulus Oncology eyes further growth as US office is set to open this year